ATLANTA, Sept. 18, 2019 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading cardiac and vascular surgery company
focused on aortic disease, announced today that it will participate
in a fireside chat with analysts and investors at the upcoming
Deutsche Bank 27th Annual Leveraged Finance Conference
on Wednesday, September 25, 2019 at
The Phoenician in Scottsdale,
AZ.
The Company's session is scheduled to begin at 8:00 a.m. MST and will feature an overview of the
company by Ashley Lee, Executive
Vice President, COO and CFO.
The live webcast can be accessed through CryoLife's website,
www.cryolife.com, on the Investor Relations page. An archived
copy of the webcast will be available for 90 days on the same
website.
About CryoLife, Inc.
Headquartered in suburban
Atlanta, Georgia, CryoLife is a
leader in the manufacturing, processing, and distribution of
medical devices and implantable tissues used in cardiac and
vascular surgical procedures focused on aortic repair.
CryoLife markets and sells products in more than 100 countries
worldwide. For additional information about CryoLife, visit
our website, www.cryolife.com.
Contacts:
|
CryoLife
D.
Ashley
Lee
Executive Vice President, Chief Financial Officer
and Chief Operating Officer
Phone:
770-419-3355
|
Gilmartin Group
LLC
Greg Chodaczek / Lynn Lewis
Phone: 646-924-1769
investors@cryolife.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryolife-to-participate-in-the-deutsche-bank-27th-annual-leveraged-finance-conference-300920542.html
SOURCE CryoLife, Inc.